Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.2420
-0.0430 (-15.09%)
Sep 11, 2026, 12:42 PM AEST
ASX:PAR Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -56.33 | -18.77 | -58.73 | -51.91 | -39.25 |
Depreciation & Amortization | 0.15 | 0.15 | 0.15 | 0.15 | 0.19 |
Loss (Gain) From Sale of Assets | 0.01 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | 2.53 | - | - | - |
Stock-Based Compensation | 1.68 | 0.1 | 1.2 | 0.94 | 3.27 |
Other Operating Activities | 2.65 | -0.11 | 0.05 | 0.3 | -0.86 |
Change in Accounts Receivable | -6.72 | -0.29 | 1.36 | 0.36 | 1.79 |
Change in Accounts Payable | 14.42 | -0.09 | -9.34 | 5.07 | 2.1 |
Change in Other Net Operating Assets | 0.45 | 0.48 | -0.63 | -0.1 | 0.54 |
Operating Cash Flow | -43.69 | -15.99 | -65.94 | -45.19 | -32.21 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Sale of Property, Plant & Equipment | 0.01 | - | - | - | - |
Sale (Purchase) of Intangibles | -0.49 | - | - | - | - |
Investment in Securities | -0.07 | 0.05 | - | - | - |
Investing Cash Flow | -0.55 | 0.05 | - | - | - |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | 25.42 | - | - | - | - |
Total Debt Issued | 25.42 | - | - | - | - |
Short-Term Debt Repaid | -2.25 | - | - | - | - |
Long-Term Debt Repaid | -0.13 | -0.13 | -0.1 | -0.1 | -0.14 |
Lease Payments | -0.13 | -0.13 | -0.1 | -0.1 | -0.14 |
Total Debt Repaid | -2.38 | -0.13 | -0.1 | -0.1 | -0.14 |
Net Debt Issued (Repaid) | 23.04 | -0.13 | -0.1 | -0.1 | -0.14 |
Issuance of Common Stock | 21.65 | 16 | 30.12 | 66.4 | 0.21 |
Other Financing Activities | -1 | -0.88 | -1.84 | -3.76 | - |
Financing Cash Flow | 43.69 | 14.99 | 28.18 | 62.53 | 0.07 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | -0.9 | -0.05 | -0.74 | -0.69 | 0.77 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 |
Net Cash Flow | -1.45 | -1 | -38.51 | 16.66 | -31.36 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -43.69 | -15.99 | -65.94 | -45.19 | -32.21 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | -40650.90% |
Free Cash Flow Per Share | -0.12 | -0.05 | -0.23 | -0.18 | -0.14 |
Levered Free Cash Flow | -28.63 | -14.29 | -49.02 | -31.18 | -22.04 |
Unlevered Free Cash Flow | -27.09 | -14.29 | -49.01 | -31.17 | -22.02 |
Free Cash Flow After Leases | -43.82 | -16.12 | -66.05 | -45.29 | -32.34 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 |
Cash Income Tax Paid | -0.84 | -6.3 | -7.33 | -7.4 | -9.53 |
Change in Working Capital | 8.15 | 0.1 | -8.61 | 5.33 | 4.44 |